Atezolizumab in combination with carboplatin plus nab‐paclitaxel for managing combined large‐cell neuroendocrine carcinoma: A case report

Large‐cell neuroendocrine carcinomas (LCNECs), categorized as high‐grade neuroendocrine carcinomas, account for approximately 3% of resected lung cancers. LCNECs containing other components are called ‘combined LCNECs’ and have no standard treatment. A 73‐year‐old male with a metastatic brain tumour...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsutsumi, Rei, Kataoka, Nobutaka, Kunimatsu, Yusuke, Sato, Izumi, Tanimura, Mai, Nakano, Takayuki, Tanimura, Keiko, Takeda, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171681/
https://www.ncbi.nlm.nih.gov/pubmed/35685848
http://dx.doi.org/10.1002/rcr2.989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171681/
https://www.ncbi.nlm.nih.gov/pubmed/35685848
http://dx.doi.org/10.1002/rcr2.989

Ejemplares similares